Nasopharyngeal colonization by Streptococcus pneumoniae is an important initial step for the subsequent development of pneumococcal infections. Pneumococci have many virulence factors that play a role in colonization. Pneumolysin (PLY), a pivotal pneumococcal virulence factor for invasive disease, causes severe tissue damage and inflammation with disruption of epithelial tight junctions. In this study, we evaluated the role of PLY in nasal colonization of S. pneumoniae using a mouse colonization model. A reduction of numbers of PLY-deficient pneumococci recovered from nasal tissue, as well as nasal wash, was observed at days 1 and 2 post-intranasal challenges, but not later. The findings strongly support an important role for PLY in the initial establishment nasal colonization. PLY-dependent invasion of local nasal mucosa may be required to establish nasal colonization with S. pneumoniae. The data help provide a rationale to explain why an organism that exists as an asymptomatic colonizer has evolved virulence factors that enable it to occasionally invade and kill its hosts. Thus, the same pneumococcal virulence factor, PLY that can contribute to killing the host, may also play a role early in the establishment of nasopharynx carriage.

Department of Microbiology University of Alabama at Birmingham Birmingham AL USA

Department of Otorhinolaryngology Head and Neck Surgery Wakayama Medical University 811 1 Kimiidera Wakayama shi Wakayama 640 8501 Japan

Zobrazit více v PubMed

J Infect Dis. 1998 Feb;177(2):368-77 PubMed

Infect Immun. 1995 Feb;63(2):442-7 PubMed

J Bacteriol. 1992 Jan;174(2):610-8 PubMed

Infect Immun. 2001 Jun;69(6):3755-61 PubMed

Infect Immun. 1984 Mar;43(3):1085-7 PubMed

Infect Immun. 2000 Feb;68(2):492-501 PubMed

Infect Immun. 1994 Apr;62(4):1501-3 PubMed

Vaccine. 2000 Dec 8;19 Suppl 1:S87-95 PubMed

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11140-4 PubMed

Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S797-805 PubMed

J Infect Dis. 1980 Dec;142(6):923-33 PubMed

Paediatr Respir Rev. 2012 Dec;13(4):258-64 PubMed

J Clin Microbiol. 1977 Mar;5(3):293-6 PubMed

Lancet. 2011 Dec 3;378(9807):1962-73 PubMed

J Bacteriol. 1986 Dec;168(3):1463-5 PubMed

Infect Immun. 2005 Oct;73(10):6945-51 PubMed

Infect Immun. 1989 Jul;57(7):2037-42 PubMed

J Infect Dis. 2004 Nov 1;190(9):1661-9 PubMed

Immunology. 1986 Dec;59(4):515-20 PubMed

Infect Immun. 2002 Jun;70(6):2886-90 PubMed

J Immunol. 2002 Feb 15;168(4):1886-94 PubMed

MBio. 2013 Sep 10;4(5):e00655-13 PubMed

Infect Immun. 2007 Apr;75(4):1843-51 PubMed

J Clin Invest. 1995 Jan;95(1):142-50 PubMed

Trends Microbiol. 1996 Mar;4(3):103-6 PubMed

J Infect Dis. 2014 Jul 1;210(1):25-34 PubMed

Cell Microbiol. 2005 Oct;7(10 ):1404-17 PubMed

Mol Microbiol. 1991 Nov;5(11):2611-6 PubMed

Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3429-34 PubMed

J Infect Dis. 1975 Jul;132(1):62-8 PubMed

Infect Immun. 1989 Jul;57(7):2006-13 PubMed

Am J Respir Cell Mol Biol. 1991 Nov;5(5):416-23 PubMed

Microb Pathog. 1998 Dec;25(6):337-42 PubMed

Infect Immun. 1983 Sep;41(3):1212-6 PubMed

J Infect Dis. 1997 Jun;175(6):1440-5 PubMed

J Immunol. 2004 Jul 1;173(1):471-7 PubMed

Infect Immun. 1993 Apr;61(4):1352-8 PubMed

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1339-46 PubMed

Infect Immun. 2000 Jan;68(1):133-40 PubMed

Pathog Dis. 2014 Apr;70(3):280-8 PubMed

Front Cell Infect Microbiol. 2014 Nov 06;4:163 PubMed

Microbiol Mol Biol Rev. 2001 Jun;65(2):187-207 ; first page, table of contents PubMed

Infect Immun. 1992 May;60(5):1740-6 PubMed

Infect Immun. 2004 Jan;72(1):114-22 PubMed

J Immunol. 2011 Jul 1;187(1):434-40 PubMed

J Exp Med. 1981 Mar 1;153(3):694-705 PubMed

PLoS One. 2011;6(12):e28738 PubMed